ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
- Funded by Biomedical Advanced Research and Development Authority (BARDA)
- Total publications:0 publications
Grant number: 75A50123C00056
Grant search
Key facts
Disease
COVID-19, UnspecifiedStart & end year
20232028Known Financial Commitments (USD)
$110,049,162Funder
Biomedical Advanced Research and Development Authority (BARDA)Research Location
United States of AmericaLead Research Institution
MODEX THERAPEUTICS, INCResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.